Chief Complaint: “I see people outside my home.”
History of Present Illness:
A 51-year-old female, legally blind due to a complicated ocular history including proliferative diabetic retinopathy OU, history of combined tractional-rhegmatogenous retinal detachment OU, and mixed mechanism glaucoma, reported to clinic for routine follow-up. Overall, her vision was stable since her last visit, however, she had noticed occasional “snow” in her vision. Upon further questioning, she also reported episodes of vivid visual hallucinations, including seeing people walking around outside whom she knew were not really there. These did not occur at specific times of day and varied in their duration.
Past Ocular History:
Past Medical History:
Allergies: Sulfa, neomycin & polymyxin
Family History: : No pertinent family history
Social History: Non-contributory
Review of Systems: : A review of the neurological system was performed and was negative except for a history of neuropathy of the distal lower extremities. The ocular system was also reviewed, and the findings are described above in the history of present illness.
Visual hallucinations can be due to:
This patient was diagnosed with Charles Bonnet Syndrome (CBS), a condition characterized by the occurrence of visual hallucinations in patients with diminished visual acuity, usually those with severe vision loss in both eyes. CBS is a diagnosis of exclusion that often goes unrecognized or is misdiagnosed [1 ,2]. While typically not disabling, CBS may cause significant distress to patients . This article will review the etiology, epidemiology, pathophysiology, clinical characteristics, differential diagnosis, and treatment of this condition.
Charles Bonnet Syndrome is relatively common, with an estimated prevalence of 10-40% in visually impaired patients [3-5]. The visual hallucinations in CBS have been described with conditions of visual loss affecting any part of the visual system, including the eye, optic nerve, and brain [2 ,6], and may occur in almost any acquired disorder of the visual system [1 ,2 ,7 ,8]. The most common conditions among patients with CBS include age-related macular degeneration, glaucoma, diabetic retinopathy, and stroke.
Hallucinations in CBS may manifest at the same time as acute vision loss or after a brief period of latency, ranging from hours to several weeks . One cross-sectional analysis of patients with retinal disease found that 61.5% of those patients with CBS reported a duration of hallucinations of less than 1 year . Despite the myriad of conditions contributing to CBS, the majority of patients had not previously reported their symptoms to their physician or family members prior to diagnosis, indicating that the condition may be more prevalent than is often thought, and highlighting the hesitancy that patients may have regarding sharing their symptoms, even with close relatives [1 ,2].
Visual hallucinations of CBS have been reported in patients of all ages . However, CBS has not been reported in patients with congenital blindness . Several studies have found advanced age to be a risk factor for development of CBS, with one study noting a significant association between development of hallucinations and age over 64 years [4 ,8 ,12]. The greater prevalence of CBS in older patients likely corresponds to the increasing prevalence of common conditions causing vision loss, such as age-related macular degeneration or advanced glaucoma . Other risk factors which have been implicated in the development of CBS include visual acuity worse than 20/60, binocular disease, cognitive impairment, cerebrovascular disease, cortical atrophy, and social deprivation [4 ,12].
Visual hallucinations in the setting of CBS have a variety of manifestations. Some patients report simple images, such as lines, flashes of light, or patterns. Other patients may experience more complex visual hallucinations such as those of animals or people . These images may be static or animated and may last seconds or several hours. Studies suggest that simple hallucinations (51%) are more common than complex hallucinations (21%), although there may be significant variation in complexity even within individual patients . Hallucinations typically correspond with the laterality of visual loss, but may occur in one or both eyes, or in part of the visual field .
One of the most important distinguishing features of visual hallucinations secondary to CBS is that the patient generally has insight into their condition and knows that the images are not real [1 ,2]. Another characteristic of hallucinations unique to CBS includes that they predominately occur when the eyes are open, and tend to resolve when a patient closes their eyes or looks away [6 ,17]. One study found that the hallucinations tend to be more prevalent in the setting of sensory deprivation, such as in low light situations, in social isolation, and general inactivity .
Diagnosis & Differential Diagnosis
Charles Bonnet Syndrome is largely a clinical diagnosis, and patients who experience visual hallucinations in the classic clinical context of low vision with good insight into their condition may not need diagnostic testing. However, patients with suspected visual hallucinations should undergo neurologic evaluation with screening for cognitive impairment, parkinsonism, or any other deficits if clinically appropriate. A careful review of medication lists for pharmacologic agents known to cause visual hallucinations, such as digoxin, sildenafil, or anticholinergics is also advised. Screening should also be done for drugs of abuse, particularly hallucinogens, with monitoring for withdrawal from substances like alcohol and benzodiazepines. Generally, CBS can be distinguished from other causes by a lack of other neurologic deficits and the presence of known ocular disease. In the case that a patient presents with symptoms suggestive of CBS, but without known eye disease, a full ophthalmologic exam should be performed .
|Etiology||Features of Visual Hallucinations|
|Psychiatric Illness||Generally accompanied by auditory hallucinations and may be frightening to the patient, who may lack insight into the condition.|
Lewy Body Dementia
|Hallucinations usually manifest early, prior to motor symptoms and occur throughout the entire visual field.|
Creutzfeldt- Jacob Disease
|In the Heidenhain variant, patients experience poor vision and disturbed color sense in the setting of rapidly progressive dementia, myoclonus and a normal eye exam.|
|Delirium||Hallucinations may be frightening, and insight is generally limited|
|Seizures||Hallucinations are simple, brief, and consistent (colored spots/flashing shapes).|
|Migraine Aura||Patients often see flickering, zig zagging lines starting centrally and progressing peripherally. Patients generally have good insight.|
|Alcohol/Drug Use||Hallucinations are often frightening and may result from intoxication or withdrawal.|
|Metabolic Encephalopathy||Presentation is similar to delirium.|
|Peduncular Hallucinosis||Related to thalamic and midbrain lesions, these hallucinations often occur in the dark and last minutes, with good insight.|
|Anton’s Syndrome||Patients confabulate their vision, insisting they are capable of seeing despite evidence of cortical blindness.|
CBS is under-recognized and underdiagnosed, and several groups have advocated for screening in order to identify affected patients. One simple approach recommends utilizing a combination of indirect and direct questioning in all patients with underlying vision loss. First, patients are asked non-leading, indirect questions:
If the patient is not forthcoming about a history of hallucinations, a more direct line of questioning can then be used .
Prognosis & Treatment
The prognosis of CBS varies widely depending upon the underlying cause of visual loss. In patients with chronic vision loss, hallucinations may persist for many years. For example, 75% of those with CBS in the context of macular disease experienced hallucinations for a period of at least 5 years . However, in the case of reversible vision loss, as with cataracts, hallucinations often resolve once vision is corrected or improved . Hallucinations may also cease over time in more progressive and permanent causes of vision loss, particularly in cases of acute cerebral injury .
No definitive treatment exists for the visual hallucinations associated with CBS, and the therapeutic approach to these patients relies primarily on providing reassurance and normalization, depending on the degree of patient distress. It is important for patients to understand that they are not alone, as there is a relatively high incidence of CBS among those with vision loss. Patients should also be reassured that these hallucinations are not a sign of psychiatric illness or dementia, as fear of being deemed “crazy” is a frequently-cited concern . Beyond reassurance, there are behavioral interventions which may benefit select patients. For instance, temporary suppression of hallucinations may be achieved in patients who utilize rapid eye movement and blinking . There is also anecdotal evidence to suggest that increased visual stimulation, arousal, and social interaction may help to suppress symptoms .
Medical management of CBS, particularly in those patients experiencing distress from their hallucinations, remains an area of controversy. Several case studies have reported symptomatic improvement following treatment with antipsychotic medications such as haloperidol, olanzapine and thiothixene, though results are largely mixed [22-25]. Certain anticonvulsive medications such as carbamazepine, clonazepam, gabapentin and valproate have also been found to be useful in case reports [26-29].
Dangremond TE, Ramirez DA, Han IC. Charles Bonnet Syndrome. EyeRounds.org. Posted September 17, 2020. Available from http://www.EyeRounds.org/cases/Charles Bonnet Syndrome.htm.
Ophthalmic Atlas Images by EyeRounds.org, The University of Iowa are licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.